Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases

Key facts

Sponsor

Hospital Universitário Professor Edgard Santos

Principal Investigator

Davi Costa, MD

Federal University of Bahia

Intervention

Pentoxifylline(drug)

Enrollment

48 target

Eligibility

18-80 years · All sexes

Timeline

2009 – 2012

Study locations (1)

• Hospital Universitário Professor Edgard Santos, Salvador, Estado de Bahia, Brazil

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Tropical spastic paraparesis

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE1, PHASE2NCT04799288
  Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
  National Institute of Neurological Disorders and Stroke (NINDS)
• RECRUITINGNCT00001778
  Evaluation of Patients With HAM/TSP
  National Institute of Neurological Disorders and Stroke (NINDS)

See all trials for Tropical spastic paraparesis →